Prospective evaluation of therapeutic target attainment with a beta-lactam dosing nomogram in critically ill adult patients
Abstract
Background: Therapeutic drug monitoring (TDM) individualises antibiotic dosing, aiming for therapeutic exposures and minimising toxicity. However, TDM cannot always be performed due to resource requirements, and clinicians often dose according to guidelines. This study aimed to quantify the achievement of therapeutic exposures (concentrations) in a heterogeneous cohort of critically ill adults using nomogram-based antibiotic dosing. Methods: This was a prospective, single-centre, cohort study of nomogram-based dosing of beta-lactams in critically ill adults. The primary outcome was the proportion of patients with therapeutic exposures, that is those above the efficacy threshold but below the toxic threshold. Secondary endpoints were exposures associated with toxicity, and the relationship between exposure and clinical outcomes. Results: In 79 patients, therapeutic beta-lactam exposure was achieved in 82% (63/77) and 81% (35/43) of patients at days 1 to 3 and days 4 to 6, respectively. Piperacillin yielded the lowest therapeutic attainment, with 75% (24/32) and 71% (12/17) at days 1 to 3 and days 4 to 6, respectively, and the highest proportion of sub-therapeutic exposures: 25% (8/32) and 29% (5/17), respectively. Therapeutic tazobactam trough concentrations were achieved in 66% (21/32) and 65% (11/17) of patients at days 1 to 3 and days 4 to 6, respectively. Conclusions: In a single-centre heterogeneous population of critically ill adults with infection, initial dosing informed by a dosing nomogram for beta-lactams resulted in a high proportion of patients achieving therapeutic exposures.
Related
- Electronic-Nomogram-Guided Micafungin Dosing Regimen in Critically Ill Patients: A Population Pharmacokinetic Study
- Development and validation of a nomogram for predicting 28-day mortality in critically ill liver cirrhotic patients with coagulopathy
- Optimising Therapeutic Target Attainment in Vancomycin Therapy for Patients Requiring Intermittent Haemodialysis
- Albumin Supplementation Preserves Systemic Antioxidant Defenses in Critically Ill, Septic Patients: A Prospective Comparative Study
- Evaluation of Model-Informed Precision Dosing of Cefepime in Critically Ill Patients: A French Before–After Study
BibTeX
@article{williams2026prospective,
title = {{Prospective evaluation of therapeutic target attainment with a beta-lactam dosing nomogram in critically ill adult patients}},
author = {Paul Williams and Menino Osbert Cotta and Mohd Abdul-Aziz and Kathryn Wilks and Lauren Murray and Steven Wallis and Gareth Beall and Jason A. Roberts},
journal = {International Journal of Antimicrobial Agents},
year = {2026},
month = oct,
doi = {10.1016/j.ijantimicag.2026.107883},
url = {https://hal.science/hal-05826193v1},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Prospective evaluation of therapeutic target attainment with a beta-lactam dosing nomogram in critically ill adult patients
AU - Paul Williams
AU - Menino Osbert Cotta
AU - Mohd Abdul-Aziz
AU - Kathryn Wilks
AU - Lauren Murray
AU - Steven Wallis
AU - Gareth Beall
AU - Jason A. Roberts
PY - 2026
DA - 2026/10/20
JO - International Journal of Antimicrobial Agents
DO - 10.1016/j.ijantimicag.2026.107883
UR - https://hal.science/hal-05826193v1
AB - Background: Therapeutic drug monitoring (TDM) individualises antibiotic dosing, aiming for therapeutic exposures and minimising toxicity. However, TDM cannot always be performed due to resource requirements, and clinicians often dose according to guidelines. This study aimed to quantify the achievement of therapeutic exposures (concentrations) in a heterogeneous cohort of critically ill adults using nomogram-based antibiotic dosing. Methods: This was a prospective, single-centre, cohort study of nomogram-based dosing of beta-lactams in critically ill adults. The primary outcome was the proportion of patients with therapeutic exposures, that is those above the efficacy threshold but below the toxic threshold. Secondary endpoints were exposures associated with toxicity, and the relationship between exposure and clinical outcomes. Results: In 79 patients, therapeutic beta-lactam exposure was achieved in 82% (63/77) and 81% (35/43) of patients at days 1 to 3 and days 4 to 6, respectively. Piperacillin yielded the lowest therapeutic attainment, with 75% (24/32) and 71% (12/17) at days 1 to 3 and days 4 to 6, respectively, and the highest proportion of sub-therapeutic exposures: 25% (8/32) and 29% (5/17), respectively. Therapeutic tazobactam trough concentrations were achieved in 66% (21/32) and 65% (11/17) of patients at days 1 to 3 and days 4 to 6, respectively. Conclusions: In a single-centre heterogeneous population of critically ill adults with infection, initial dosing informed by a dosing nomogram for beta-lactams resulted in a high proportion of patients achieving therapeutic exposures.
SN - 0924-8579
SN - 1872-7913
ER -